TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32224022

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercises for 30 minutes
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (rested)
Number of subjects: 58
Study: 34460098

Group type: EXPERIMENTAL
Intervention: FallTIPS fall prevention program
Number of subjects: 298
Study: 34048680

Group type: EXPERIMENTAL
Intervention: A+AVD (brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine)
Number of subjects: 1334

Group type: COMPARATOR
Intervention: ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Number of subjects: 1334

Group type: EXPERIMENTAL
Intervention: A+AVD (among PET-2-negative patients)
Number of subjects: 1334

Group type: COMPARATOR
Intervention: ABVD (among PET-2-negative patients)
Number of subjects: 1334

Group type: EXPERIMENTAL
Intervention: A+AVD (among PET-2-positive patients)
Number of subjects: 1334

Group type: COMPARATOR
Intervention: ABVD (among PET-2-positive patients)
Number of subjects: 1334

Group type: EXPERIMENTAL
Intervention: A+AVD
Number of subjects: 1334

Group type: COMPARATOR
Intervention: ABVD
Number of subjects: 1334
Study: 32072216

Group type: EXPERIMENTAL
Intervention: Subbrow blepharoplasty combined with periorbital muscle manipulation (SBB‐pm)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Subbrow blepharoplasty (SBB)
Number of subjects: 70
Study: 616191571

Group type: EXPERIMENTAL
Intervention: Cebranopadol (200/400/600/800/1000 mug, flexible titration, QD)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Morphine sulfate prolonged release (previous treatment)
Number of subjects: 76
Study: 34670008

Group type: EXPERIMENTAL
Intervention: Cenobamate (50, 100, 200, and 400 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33057829

Group type: EXPERIMENTAL
Intervention: Absorbable dermal stapler
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional suturing
Number of subjects: 30
Study: 32641094

Group type: EXPERIMENTAL
Intervention: Subsidized malaria rapid diagnostic test (mRDT) kits introduced after training of OTCMS
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 13
Study: 35131740

Group type: EXPERIMENTAL
Intervention: Behavioural Intervention Team (BIT)
Number of subjects: 3800

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3800
Study: 36182235

Group type: EXPERIMENTAL
Intervention: Accelerated partner therapy (usual care plus an offer of accelerated partner therapy)
Number of subjects: 1536

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1536

Group type: EXPERIMENTAL
Intervention: Accelerated partner therapy
Number of subjects: 1536
Study: 32986293

Group type: EXPERIMENTAL
Intervention: Head down tilt 15° (HDT15°) for 1 hour
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Head down tilt 15° (HDT15°)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Flat position (control)
Number of subjects: 64
Study: 35090531

Group type: EXPERIMENTAL
Intervention: OptiMA strategy (ready-to-use therapeutic food at gradually tapered doses)
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: ComPAS strategy (ready-to-use therapeutic food at gradually tapered doses)
Number of subjects: 567

Group type: COMPARATOR
Intervention: Standard nutritional protocol of Niger
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: All strategies (OptiMA, ComPAS, Standard)
Number of subjects: 567
Study: 33733692

Group type: EXPERIMENTAL
Intervention: IV plus IVT treatment
Number of subjects: 74

Group type: COMPARATOR
Intervention: Systemic antibiotic treatment
Number of subjects: 74
Study: 32912971

Group type: EXPERIMENTAL
Intervention: Oestrogen treatment (oestradiol hemihydrate 10 μg vaginal pessaries)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No oestrogen treatment
Number of subjects: 100
Study: 36286256

Group type: EXPERIMENTAL
Intervention: Increased early mobilization (sedation minimization and daily physiotherapy)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Usual care (normal level of mobilization in each ICU)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Increased early mobilization
Number of subjects: 750

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 750
Study: 33761016

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) therapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells (MSCs)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Modified PRP formulas (PRF, PRGF)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: PRP therapy in degenerative disc disease, facet arthropathy, and sacroiliitis
Number of subjects: 18
Study: 32527065

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines (CHMs)
Number of subjects: 2670

Group type: COMPARATOR
Intervention: Non-CHMs
Number of subjects: 2670
Study: 34117531

Group type: EXPERIMENTAL
Intervention: Twice-weekly progressive resistance training (PRT) and daily swallowing exercises throughout treatment
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 240
Study: 34064996

Group type: EXPERIMENTAL
Intervention: 10 g of leucine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 10 g of isoleucine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 10 g of valine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study: 35759349

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 33097384

Group type: EXPERIMENTAL
Intervention: Home-Based Kidney Care (HBKC)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 63
Study: 36280033

Group type: EXPERIMENTAL
Intervention: Emergency laparoscopic appendectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Symptomatic treatment
Number of subjects: 0
Study: 33485831

Group type: EXPERIMENTAL
Intervention: NaHCO3 at 0.08% Na
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: NaHCO3 at 0.18% Na
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: NaHCO3 at 0.23% Na
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: NaHCO3 at 0.33% Na
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Na2SO4 at 0.08% Na
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Na2SO4 at 0.18% Na
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Na2SO4 at 0.23% Na
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Na2SO4 at 0.33% Na
Number of subjects: 576
Study: 35191141

Group type: EXPERIMENTAL
Intervention: Yoga intervention for 20 weeks
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group (no yoga)
Number of subjects: 208
Study: 34337905

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (60,000 IU of colecalciferol monthly)
Number of subjects: 21315

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21315
Study: 32481345

Group type: EXPERIMENTAL
Intervention: Isokinetic training (IKT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Core stabilization training (CST)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 34998508

Group type: EXPERIMENTAL
Intervention: i.v. TXA 1 g
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: i.m. TXA 1 g
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: oral TXA solution 2 g
Number of subjects: 15
Study: 33571267

Group type: EXPERIMENTAL
Intervention: Iron containing micronutrient powder supplementation (12.5 mg elemental iron, vitamin A 400 μg, ascorbic acid 30 mg, zinc 5 mg)
Number of subjects: 1958

Group type: COMPARATOR
Intervention: Placebo micronutrient powder (without iron)
Number of subjects: 1958

Group type: EXPERIMENTAL
Intervention: Iron containing micronutrient powder supplementation
Number of subjects: 1958
Study: 32604255

Group type: EXPERIMENTAL
Intervention: Interval-type (IT) aerobic exercise program
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Continuous-type (CT) aerobic exercise program
Number of subjects: 72

Group type: COMPARATOR
Intervention: Home-based exercise (HE) program
Number of subjects: 72
Study: 34625784

Group type: EXPERIMENTAL
Intervention: WT1 MRDhigh (defined as a WT1 MRD ratio >2.5% in bone marrow or >0.5% in peripheral blood)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: WT1 MRDlow (defined as a WT1 MRD ratio ≤2.5% in bone marrow or ≤0.5% in peripheral blood)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Allogeneic stem cell transplantation (allo-SCT)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: MRD response in patients with intermediate-/unfavorable-risk AML eligible for allo-SCT
Number of subjects: 314
Study: 32510976

Group type: EXPERIMENTAL
Intervention: Guided bronchial thermoplasty (BT) after one session
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unguided bronchial thermoplasty (BT) after three sessions
Number of subjects: 30
Study: 34964458

Group type: EXPERIMENTAL
Intervention: Somapacitan 0.16 mg/kg/wk
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Somapacitan (pooled groups)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Daily GH
Number of subjects: 59
Study: 32961500

Group type: EXPERIMENTAL
Intervention: One-day Acceptance and Commitment Therapy workshop
Number of subjects: 430

Group type: COMPARATOR
Intervention: One-day education and attention control workshop
Number of subjects: 430
Study: 34292628

Group type: EXPERIMENTAL
Intervention: Promotility drug
Number of subjects: 77

Group type: COMPARATOR
Intervention: Surgical patients
Number of subjects: 77
Study: 32294244

Group type: EXPERIMENTAL
Intervention: L-PRF + ABG
Number of subjects: 44

Group type: COMPARATOR
Intervention: EMD + ABG
Number of subjects: 44
Study: 36028825

Group type: EXPERIMENTAL
Intervention: Transition Community Adherence Club (TCAC) intervention
Number of subjects: 16
Study: 32712460

Group type: EXPERIMENTAL
Intervention: Ready-to-use supplementary food (RUSF), 1–3 sachets for 8 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 100
Study: 35984607

Group type: EXPERIMENTAL
Intervention: DOT Diary (automated directly observed therapy)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 100
Study: 33544370

Group type: EXPERIMENTAL
Intervention: Real cerebellar rTMS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham cerebellar rTMS
Number of subjects: 20
Study: 32712009

Group type: EXPERIMENTAL
Intervention: Anti-pressure gel pads
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine institutional policy (Control)
Number of subjects: 100
Study: 35102948

Group type: EXPERIMENTAL
Intervention: Ketamine-fentanyl
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol-fentanyl
Number of subjects: 80
Study: 33839207

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting early metastasis (EM) in NPC patients
Number of subjects: 9021

Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 9021

Group type: EXPERIMENTAL
Intervention: Threshold probability of 5.0% for clinical decision-making
Number of subjects: 9021
Study: 36397422

Group type: EXPERIMENTAL
Intervention: S2 strategy of deep transfer learning based on DenseNet201
Number of subjects: 8400

Group type: COMPARATOR
Intervention: S0 strategy of deep transfer learning based on DenseNet201
Number of subjects: 8400

Group type: COMPARATOR
Intervention: S1 strategy of deep transfer learning based on DenseNet201
Number of subjects: 8400

Group type: COMPARATOR
Intervention: S3 strategy of deep transfer learning based on DenseNet201
Number of subjects: 8400
Study: 33714801

Group type: EXPERIMENTAL
Intervention: NNS on an emptied breast
Number of subjects: 33

Group type: COMPARATOR
Intervention: NNS pacifier
Number of subjects: 33
Study: 32615047

Group type: EXPERIMENTAL
Intervention: Mandarin CV-words
Number of subjects: 40

Group type: COMPARATOR
Intervention: English nonsense syllables
Number of subjects: 40
Study: 35545995

Group type: EXPERIMENTAL
Intervention: delafloxacin 300 mg
Number of subjects: 98

Group type: COMPARATOR
Intervention: moxifloxacin 400 mg
Number of subjects: 98
Study: 33066735

Group type: EXPERIMENTAL
Intervention: Bonfils
Number of subjects: 30

Group type: COMPARATOR
Intervention: SensaScope
Number of subjects: 30
Study: 35809892

Group type: EXPERIMENTAL
Intervention: Late gadolinium‐enhanced cardiac magnetic resonance (LGE‐CMR) with an image intensity ratio (IIR) threshold of >1.21 for detecting right atrial fibrosis.
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: LGE‐CMR with an IIR threshold of >1.29 for differentiating interstitial fibrosis from dense scar.
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Correlation of IIR values with endocardial bipolar voltage map in patients undergoing AF ablation.
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Comparison of electroanatomical map and LGE‐CMR for characterizing fibrosis.
Number of subjects: 53
Study: 33609794

Group type: EXPERIMENTAL
Intervention: TNF‐α inhibitors
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Janus‐kinase inhibitors
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: anti‐IL1 agents
Number of subjects: 134
Study: 33175637

Group type: EXPERIMENTAL
Intervention: PER.C6‐based Sabin‐IPV (sIPV, 15:35:112.5 DU/dose)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional Salk‐IPV (cIPV, 40:8:32 DU/dose)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PER.C6‐based Sabin‐IPV (sIPV)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional Salk‐IPV (cIPV)
Number of subjects: 32
Study: 34749586

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 40
Study: 34206188

Group type: EXPERIMENTAL
Intervention: Continuous Femoral Nerve Block (CFNB)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Continuous Femoral Triangle Block (CFTB)
Number of subjects: 40
Study: 36459369

Group type: EXPERIMENTAL
Intervention: Calcitriol 0.25 µg/day 1 week before parathyroidectomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no Calcitriol)
Number of subjects: 80
Study: 34153942

Group type: EXPERIMENTAL
Intervention: Strengthening of hip abduction (HABD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strengthening of hip extension (HEXT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strengthening of hip external rotation (HER)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Weakness of hip musculature (HABD, HEXT, HER)
Number of subjects: 0
Study: 35575012

Group type: EXPERIMENTAL
Intervention: Weekly patient-reported outcome—common terminology criteria for adverse event assessments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Every 6-week assessment of Quality of Life Questionnaire Core 30
Number of subjects: 0

Group type: COMPARATOR
Intervention: Every 6-week assessment of patient-reported outcome—common terminology criteria for adverse event nausea
Number of subjects: 0
Study: 36123858

Group type: EXPERIMENTAL
Intervention: COC1 (20 µg ethinyl estradiol/150 mg desogestrel)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: COC2 (30 µg ethinyl estradiol/3 mg drospirenone)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group (non-users)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: COC1 and COC2
Number of subjects: 127
Study: 34185864

Group type: EXPERIMENTAL
Intervention: Chest compressions performed in dental chairs (DCs) with structural support designs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chest compressions performed in dental chairs (DCs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chest compressions performed on the floor
Number of subjects: 0
Study: 35014049

Group type: EXPERIMENTAL
Intervention: mOIT with total maintenance dose of 300 mg protein
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: mOIT with total maintenance dose of 1200 mg protein
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: mOIT with fixed-dose omalizumab
Number of subjects: 60
Study: 33046320

Group type: EXPERIMENTAL
Intervention: Trauma Shears (TS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Motorized Diamond Disc Ring Cutter (MDDRC)
Number of subjects: 30
Study: 35213488

Group type: EXPERIMENTAL
Intervention: Illustrated comprehensive children's book
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional consent (Control Group)
Number of subjects: 80
Study: 34452934

Group type: EXPERIMENTAL
Intervention: High-dose MF/IND (320/150 μg) one time a day
Number of subjects: 3154

Group type: EXPERIMENTAL
Intervention: Medium-dose MF/IND (160/150 μg) one time a day
Number of subjects: 3154

Group type: COMPARATOR
Intervention: High-dose FLU/SAL (500/50 μg) two times a day
Number of subjects: 3154
Study: 36237123

Group type: EXPERIMENTAL
Intervention: Online gatekeeping service (email-based consultations)
Number of subjects: 167
Study: 33609634

Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Body massage
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 51
Study: 36294843

Group type: EXPERIMENTAL
Intervention: Personalized melanoma genomic risk information
Number of subjects: 0
Study: 32173642

Group type: EXPERIMENTAL
Intervention: New wound dressing combined with Longxuejie capsules
Number of subjects: 80

Group type: COMPARATOR
Intervention: Longxuejie capsules (control group)
Number of subjects: 80
Study: 35781026

Group type: EXPERIMENTAL
Intervention: Misoprostol (3 mL +200 µg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham (3 mL of lactate Ringer's solution)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 11
Study: 33945544

Group type: EXPERIMENTAL
Intervention: COVID-19 vaccine
Number of subjects: 1188
Study: 33264686

Group type: EXPERIMENTAL
Intervention: Nike Vaporfly 4% (VP4)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Saucony Endorphin lightweight racing flats (FLAT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Own shoes (OWN)
Number of subjects: 18
Study: 35174575

Group type: EXPERIMENTAL
Intervention: Nurse-Delivered Within My Reach relationship education curriculum and violence screening and referrals
Number of subjects: 119
Study: 33852164

Group type: EXPERIMENTAL
Intervention: Caffeine (800 mg total, chewed gum for 5 minutes at 2-hour intervals over a 6-hour treatment period)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (chewed gum for 5 minutes at 2-hour intervals over a 6-hour treatment period)
Number of subjects: 24
Study: 32315497

Group type: EXPERIMENTAL
Intervention: Topical omiganan 2.5%
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vehicle gel (control)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Topical omiganan 1%
Number of subjects: 36
Study: 36169979

Group type: EXPERIMENTAL
Intervention: Folic acid prescription fills
Number of subjects: 866586

Group type: EXPERIMENTAL
Intervention: Folic acid (1 mg per day)
Number of subjects: 866586

Group type: EXPERIMENTAL
Intervention: Folic acid (1 mg per day) duration-response analysis
Number of subjects: 866586

Group type: COMPARATOR
Intervention: Cyanocobalamin (vitamin B12)
Number of subjects: 866586
Study: 34865112

Group type: EXPERIMENTAL
Intervention: AMPP + BAI Booster
Number of subjects: 26231

Group type: COMPARATOR
Intervention: AMPP + Bystander Intervention
Number of subjects: 26231
Study: 35482652

Group type: EXPERIMENTAL
Intervention: ESTEEM (10 sessions)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Control conditions (HIV testing and counseling, LGBQ-affirmative counseling)
Number of subjects: 254
Study: 34484377

Group type: EXPERIMENTAL
Intervention: Myofascial release and stretching techniques (3 sessions, 20 min each)
Number of subjects: 40
Study: 33220047

Group type: EXPERIMENTAL
Intervention: Very low nicotine content (VLNC) cigarettes
Number of subjects: 752

Group type: COMPARATOR
Intervention: Normal nicotine content (NNC) cigarettes (control)
Number of subjects: 752
Study: 33310419

Group type: EXPERIMENTAL
Intervention: Oral prednisolone tapering (OPT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 32067626

Group type: EXPERIMENTAL
Intervention: Mass azithromycin distribution
Number of subjects: 3

Group type: COMPARATOR
Intervention: Limiting antibiotic treatment to higher risk children
Number of subjects: 3
Study: 35353088

Group type: EXPERIMENTAL
Intervention: Immediate postextraction implant with bovine bone mineral
Number of subjects: 48

Group type: COMPARATOR
Intervention: Alveolar ridge preservation technique with implant placement 4 months later
Number of subjects: 48
Study: 33785743

Group type: EXPERIMENTAL
Intervention: Peginterferon Lambda-1a (180 mcg subcutaneous dose)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 34499193

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-Remifentanil (Group R)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dexmedetomidine-Sufentanil (Group S)
Number of subjects: 100
Study: 32869590

Group type: EXPERIMENTAL
Intervention: TEAS (transcutaneous electrical acupoint stimulation)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham TEAS
Number of subjects: 60
Study: 35793180

Group type: EXPERIMENTAL
Intervention: 10 mL epidural normal saline injection (lapa-saline group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (lapa group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (open group)
Number of subjects: 60
Study: 32586702

Group type: EXPERIMENTAL
Intervention: Nasal mask
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oronasal mask
Number of subjects: 30
Study: 35706617

Group type: EXPERIMENTAL
Intervention: Group S (small size endotracheal tube followed by exchange to standard size)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Group C (standard size endotracheal tube)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Group S
Number of subjects: 80

Group type: COMPARATOR
Intervention: Group C
Number of subjects: 80
Study: 32088913

Group type: EXPERIMENTAL
Intervention: Levetiracetam at 40 mg/kg over 10 min
Number of subjects: 61

Group type: COMPARATOR
Intervention: Fosphenytoin at 20 mg/kg phenytoin equivalents (PE)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 33962664

Group type: EXPERIMENTAL
Intervention: Moderate physical activity
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cultural and recreational activities
Number of subjects: 120
Study: 32171647

Group type: EXPERIMENTAL
Intervention: New Zealand blackcurrant extract (NZBC) 600mg (2×300mg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (2×300mg microcrystalline cellulose M102)
Number of subjects: 18